– Tyto Care announces the launch of its fingertip Pulse
Oximeter device, allowing users to measure their own blood oxygen saturation
level and heart rate from the comfort and safety of home.
– Expanding its clinic-quality remote capabilities, TytoCare users will be able to perform a remote blood oxygen exam, allowing clinicians to better monitor patients with COVID-19 and chronic lung or heart conditions.
Tyto Care, a New York City-based all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, today announced the release of its FDA-cleared fingertip Pulse Oximeter (SpO2) medical device. The Pulse Oximeter enables TytoCare users to check blood oxygen saturation levels and heart rate, which are crucial for the monitoring of chronic conditions and COVID-19.
Fingertip At-Home Pulse Oximeter Measures Blood Oxygen and Heart Rate
The Pulse Oximeter connects by cable to the TytoCare device.
Users who choose to perform the blood oxygen exam are prompted to place their
finger in the SpO2 device for 15 seconds. Upon completion of the
exam, the blood oxygen and heart rate results appear immediately on the
handheld TytoCare device and the Pulse Oximeter adaptor itself and are also
recorded within the TytoCare platform for review by the clinician and sent to
the patients’ EHR
(Electronic Health Record). If the examination is performed in real-time
during a live telehealth visit, the clinician will see the results immediately
in the TytoCare Clinician Dashboard. Clinicians are able to assess the
reliability of the results recorded by viewing the heart rhythm graph generated
during the exam.
Why It Matters
This expansion of Tyto Care’s virtual examination solution
is bringing the company even closer to full remote, clinic-level testing
capabilities from the comfort of home. The Pulse Oximeter is a key tool for
monitoring high-risk or infected individuals during the COVID-19 pandemic, as
well as for post-discharge care and home hospitalization. The company’s Pulse
Oximeter device also enables seamless monitoring of patients with chronic lung
and heart conditions, critical during routine times as well.
“We’re excited to announce the release of our Pulse Oximeter, providing patients with more tests that bring the clinic directly to them,” said Dedi Gilad, CEO and Co-Founder of Tyto Care. “The COVID-19 pandemic thrust telehealth into the spotlight, and we are constantly enhancing the TytoCare platform to ensure users have access to the most comprehensive telehealth solution available. The pandemic will eventually be behind us, yet telehealth will remain a key component in the future of healthcare, providing patients with the best possible remote care and clinicians with actionable insights into their patients’ health.”
Availability
The SpO2 device is available in the
United States and Israel through partnering health systems. In the future, the
device will also be available in Europe, South Africa, and Asia.
